Pankaj G. Jain

410 citations

21 papers · 276 indexed · h-index 9

Pharmacology top 10%
- Hibiscus Plant Research Studies 3
Biochemistry
Complementary and alternative medicine
- Herbal Medicine Research Studies 2
Endocrinology, Diabetes and Metabolism
- Natural Antidiabetic Agents Studies 4
Plant Science
- Ethnobotanical and Medicinal Plants Studies 2
- Moringa oleifera research and applications 2
Pharmaceutical Science
- Drug Solubulity and Delivery Systems 2
Surgery
- Natural Products and Biological Research 2
Food Science
- Polysaccharides Composition and Applications 2

Co-authors: Sanjay J. Surana Savita D. Patil Sachin D. Shinde Umesh B. Mahajan Rameshwar S. Cheke Shailesh S. Chalikwar Pankaj Dangre Sandip D. Firke
Cited by: Pharmacology Biochemistry Complementary and alternative medicine
Partner nations: India United States

In The Last Decade

Pankaj G. Jain

21 papers receiving 246 citations

Peers

Countries citing papers authored by Pankaj G. Jain

Since Specialization

Citations

This map shows the geographic impact of Pankaj G. Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pankaj G. Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pankaj G. Jain more than expected).

Fields of papers citing papers by Pankaj G. Jain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pankaj G. Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pankaj G. Jain. The network helps show where Pankaj G. Jain may publish in the future.

Co-authorship network

The 15 scholars most cited alongside Pankaj G. Jain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pankaj G. Jain Line = papers co-authored together Pankaj G. Jain links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Investigating the protective effects of luteolin and gallic acid from Luffa acutangulavar. amara (Roxb.) C. B. Clarke. Fruit pericarp against alcohol-induced liver toxicity: Extraction, bioactivity-guided fractionation, molecular docking, and dynamics studies Mohan Kalaskar,S. Prabhu,Muniappan Ayyanar,Vivekkumar K. Redasani,Sandip D. Firke,Md. Mujeeb G. Khan,Saurabh C. Khadse,Pankaj G. Jain,Sanjay J. Surana,Shailendra Gurav	2025	2
2	Footprints of Nanocarrier on multi drug resistance therapy Sayali Aher,Afsar S. Pathan,Pankaj G. Jain,Shreyash Yadav,Eknath D. Ahire	2024	1
3	Nanodiamond: Insight from Introduction to Application Pankaj G. Jain,Afsar S. Pathan,Yashshri S. Jadhav,Sanjay J. Surana	2022	2
4	Neuroprotective Effects of P-Coumaric Acid on Haloperidol-Induced Catalepsy Through Ameliorating Oxidative Stress and Brain Dopamine Level Afsar S. Pathan,Pankaj G. Jain,Vivek S. Kumawat,Ujwal Katolkar,Sanjay J. Surana	2022	5
5	Development and exploration on flowability of solid self-nanoemulsifying drug delivery system of morin hydrate Pankaj Dangre,Shital B. Shinde,Sanjay J. Surana,Pankaj G. Jain,Shailesh S. Chalikwar	2022	8
6	Abrogation of cisplatin-induced nephrotoxicity in rats and HEK-293 cell lines by formononetin: in vivo and in vitro study Sachin D. Shinde,Pankaj G. Jain,Rameshwar S. Cheke,Sanjay J. Surana,Shivshankar M. Gunjegaonkar	2021	8
7	Natural Product Emerging as Potential SARS Spike Glycoproteins-ACE2 Inhibitors to Combat COVID-19 Attributed by In-Silico Investigations Rameshwar S. Cheke,Rohan R. Narkhede,Sachin D. Shinde,Jaya P. Ambhore,Pankaj G. Jain,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2020	10
8	Repurposing of Anthelmintic Drugs against SARS-CoV-2 (Mpro and RdRp): Novel Disease, Older Therapeutics Rameshwar S. Cheke,Rohan R. Narkhede,Sachin D. Shinde,Jaya P. Ambhore,Pankaj G. Jain,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2020	2
9	The Berberis aristata Ameliorates oxazolone induced contact dermatitis: in-vivo and in silico evidences Sachin D. Shinde,Rameshwar S. Cheke,Prafulla R. Tathe,Pankaj G. Jain,Rohan R. Narkhede	2020	8
10	The possible antioxidant capabilities of formononetin in guarding against streptozotocin-induced diabetic nephropathy in rats Pankaj G. Jain,Priti G. Nayse,Dipali J. Patil,Sachin D. Shinde,Sanjay J. Surana	2020	13
11	Evaluation of the Antiasthmatic Activity of Methanolic Extract of Trigonella Foenum Graecum on Experimental Models of Bronchial Asthma Pankaj G. Jain,Pramod P. Patil,Sushil D. Patil,Savita D. Patil,Sanjay J. Surana	2020	5
12	Protective Effect of Diosgenin on Streptozotocin Induced Diabetic Nephropathy in Experimental Rats Pankaj G. Jain,Dipali J. Patil,Priti G. Nayase,Sanjay J. Surana,Pramod P. Patil	2020	4
13	Cardioprotective role of FA against isoproterenol induced cardiac toxicity Pankaj G. Jain,Umesh B. Mahajan,Sachin D. Shinde,Sanjay J. Surana	2018	46
14	Ethnobotanical survey of five villages of Durg District of Chhattisgarh, (India) Devi Sangita,Kaushilya Sahu,Gunwant Chandrol,Pankaj G. Jain,Vaidehi Sharma,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2016	6
15	Comparative evaluation of antimicrobial efficacy of three different formulations of mouth rinses with multi-herbal mouth rinse Isha Jain,Pankaj G. Jain	2016	14
16	Isolation, characterization and hypolipidemic activity of ferulic acid in high-fat-diet-induced hyperlipidemia in laboratory rats Pankaj G. Jain,Sanjay J. Surana	2016	29
17	Immunomodulatory Activity ofMoringa oleiferain Albino Rats Priyanka Deshmukh,Rajesh Kumar Sharma,Varsha Sharma,Pankaj G. Jain	2015	5
18	Evaluation of Anti-Hyperlipidemic Potential of Prosopis cineraria Extract Against High Fat Diet Induced Hyperlipidemia in Laboratory Rat Pankaj G. Jain,Sanjay J. Surana	2015	2
19	Hypolipidemic activity of Moringa oleifera Lam., Moringaceae, on high fat diet induced hyperlipidemia in albino rats Pankaj G. Jain,Savita D. Patil,Nitin G. Haswani,Manoj V. Girase,Sanjay J. Surana	2010	100
20	Hypoglycemic Potential of Bridelia retusa Bark in Albino Rats Anil U. Tatiya,Ujwaldip V. Deore,Pankaj G. Jain,Sanjay J. Surana	2010	4

About Pankaj G. Jain

Pankaj G. Jain is a scholar working on Pharmaceutical Science, Pharmacology and Complementary and alternative medicine, having authored 21 papers that have together received 276 indexed citations. Recurring topics across this work include Natural Antidiabetic Agents Studies (4 papers), Hibiscus Plant Research Studies (3 papers), Ethnobotanical and Medicinal Plants Studies (2 papers), Drug Solubulity and Delivery Systems (2 papers), Natural Products and Biological Research (2 papers), Herbal Medicine Research Studies (2 papers), Moringa oleifera research and applications (2 papers) and Polysaccharides Composition and Applications (2 papers). The work is most often cited by research in Pharmacology (44 citations), Biochemistry (25 citations) and Complementary and alternative medicine (32 citations). Pankaj G. Jain has collaborated with scholars based in India and United States. Frequent co-authors include Sanjay J. Surana, Savita D. Patil, Sachin D. Shinde, Umesh B. Mahajan, Rameshwar S. Cheke, Shailesh S. Chalikwar, Pankaj Dangre, Sandip D. Firke, Vivekkumar K. Redasani and Mohan Kalaskar.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact